Latest autoimmune diseases Stories

Bob Saget Returns To Carolines On Broadway With Celebrity Friends For Cool Comedy - Hot Cuisine To Benefit Scleroderma Research Monday, October 22

2012-10-10 19:22:18

Special Guests Include Late Night's Seth Herzog, Saturday night live's Seth Meyers, The Daily Show's John Oliver, Triumph The Insult Comic Dog and Others NEW YORK, Oct. 10, 2012 /PRNewswire-USNewswire/ -- Bob Saget will host Cool Comedy - Hot Cuisine, the Scleroderma Research Foundation's (SRF) signature event on Monday, October 22 at Carolines on Broadway. Saget, an SRF Board Member who lost his sister to scleroderma, will be joined in the fundraising effort by comedians Seth...

Lesser Known Ankylosing Spondylitis Pharmacotherapy is an Untapped Market in the United States, Finds Frost & Sullivan

2012-10-10 07:27:51

MOUNTAIN VIEW, Calif., Oct. 10, 2012 /PRNewswire/ -- The treatment beyond standard of care for ankylosing spondylitis (AS) pharmacotherapeutics currently consists of a single drug class - tumor necrosis factor (TNF) inhibitors. This unavailability of alternative treatment represents an underserved and potentially significant market that is waiting for exploration. New analysis from Frost & Sullivan's (http://www.lifesciences.frost.com) United States Market for Ankylosing...

Premier Care in Bathing Marks World Arthritis Day

2012-10-09 15:24:44

LONDON, October 9, 2012 /PRNewswire/ -- Leading specialist bathing company set to raise thousands for Arthritis Research UK to help make a difference for sufferers Premier Care in Bathing is marking World Arthritis Day (12th October) by announcing that it will donate 10 per cent of sales taken on the day to Arthritis Research UK, which will amount to thousands of much needed pounds for research and development of arthritis treatments. The company, which provides...

First-ever psoriatic arthritis program in the country kicks off in Oregon

2012-10-09 15:24:36

Be Joint Smart educates public about devastating disease affecting 27,000 Oregonians PORTLAND, Ore., Oct. 9, 2012 /PRNewswire-USNewswire/ -- For the first-time ever, the Portland-based National Psoriasis Foundation and the Arthritis Foundation will partner to educate Americans about psoriatic arthritis, a chronic autoimmune disease that affects roughly 27,000 Oregonians. To emphasis the importance of early diagnosis and treatment, the Psoriasis Foundation and Arthritis Foundation...

NexDx Changes Name to Ignyta to Reflect Burning Commitment to Catalyzing the Personalized Medicine Revolution

2012-10-09 04:03:50

Ignyta’s vision is to kindle the development and usage of the most accurate molecular diagnostic tests and precisely targeted therapeutics in autoimmune diseases (AID) and to extinguish AID through earlier, more enlightened diagnosis and treatment of patients worldwide. San Diego, CA (PRWEB) October 09, 2012 NexDx, Inc. announced today that it has changed its name to Ignyta, Inc. The name change reflects the San Diego based biotechnology company’s broader commitment to catalyzing the...

Gliknik Raises $4.9 Million In Series B Financing Led By Baxter Ventures

2012-10-08 07:24:18

BALTIMORE, Oct. 8, 2012 /PRNewswire/ -- Gliknik Inc., a privately held biopharmaceuticals company creating new therapies for cancer and immune / inflammatory disorders, today announced that it has raised $4.9 million in Series B Financing. Baxter Ventures, an initiative created in 2011 by Baxter International Inc., led the Series B raise and is joined by existing investors. With the funding, Gliknik will further advance towards the clinic its IVIG-mimetic lead compound, GL-2045,...

New Technology Developed To Identify Biomarkers For Ulcerative Colitis

2012-10-04 10:45:50

Scientists from the Florida campus of The Scripps Research Institute have developed a novel technology that can identify, in animal models, potential biomarkers of ulcerative colitis, a type of inflammatory bowel disease that affects the lining of the colon. The study was published October 3, 2012, in the Journal of the American Chemical Society. The new research focuses on the protein arginine deiminases (PAD), which have been implicated in a number of diseases, including cancer,...

Excimer lasers work more than skin deep

2012-10-03 23:02:23

Advanced Dermatology medical experts on the newest approach to treating vitiligo and psoriasis. Roslyn, NY (PRWEB) October 02, 2012 October 2012 - Before his tragic death, some people thought Michael Jackson tried to lighten his skin. In reality, the star battled with vitiligo, an auto immune condition in which the skin loses melanin, the pigment that determines the color of skin, hair and eyes. If the cells that produce melanin die or no longer form melanin, slowly growing white patches...

LEO Pharma Unveils new Scientific Collaboration Strategy

2012-10-03 02:27:46

BALLERUP, Denmark, October 3, 2012 /PRNewswire/ -- LEO Pharma has announced plans to establish five long-term, strategic research collaborations in four countries by the end of next year. The ambitious initiative aims to deliver new treatment options to dermatology patients - faster than ever before. The first in the series of collaborations to be announced is with Charite, one of Europe's oldest and largest university hospitals. (Logo:...

Janssen Announces Worldwide Agreement To Develop And Commercialize JAK Inhibitor For Immunological Diseases

2012-10-01 14:21:20

HORSHAM, Pa., Oct. 1, 2012 /PRNewswire/ -- Janssen Biotech, Inc. ("Janssen") announced today that it has entered into a license agreement with Astellas Pharma Inc. ("Astellas") for the worldwide development and commercialization, except in Japan, of ASP015K, an oral, small molecule Janus Kinase (JAK) inhibitor. ASP015K is currently in Phase 2b development as a once-daily oral treatment for moderate-to-severe rheumatoid arthritis (RA), following a successful Phase 2a study...